It is believed that loss of p53 function plays a crucial role in the progression of well to poorly differentiated thyroid cancers including anaplastic thyroid carcinoma (ATC). This evidence concerns the gene TP53 and thyroid gland undifferentiated (anaplastic) carcinoma.